PMID- 27902456 OWN - NLM STAT- MEDLINE DCOM- 20171106 LR - 20211204 IS - 1945-4589 (Electronic) IS - 1945-4589 (Linking) VI - 8 IP - 11 DP - 2016 Nov 29 TI - Long-term caloric restriction in ApoE-deficient mice results in neuroprotection via Fgf21-induced AMPK/mTOR pathway. PG - 2777-2789 LID - 10.18632/aging.101086 [doi] AB - Caloric restriction (CR) decelerates the aging process, extends lifespan and exerts neuroprotective effects in diverse species by so far unknown mechanisms. Based on known neuroprotective effects of fibroblastic growth factor 21 (Fgf21) we speculate that CR upregulates Fgf21, which phosphorylates neuronal AMP-activated protein kinase (AMPK), leading to a decrease of mammalian target of rapamycin (mTOR) signaling activity and an inhibition of tau-hyperphosphorylation. This in turn reduces the formation of neurofibrillary tangles, a neuropathological hallmark of Alzheimer s disease. ApoE-deficient mice (ApoE-/-), serving as a model of neurodegeneration, showed upon CR vs. ad libitum feeding increased Fgf21 levels in both, plasma and brain as well as higher phosphorylation of fibroblastic growth factor receptor 1c (Fgfr1c), extracellular signal-regulated kinases 1/2 (ERK1/2) and AMPK in brain, lower activity of mTOR and decreased Tau-phosphorylation. Finally, CR in ApoE-/- mice caused neuroprotection as indicated by a higher synaptic plasticity shown by immunohistochemical analysis with increased numbers of PSD95-positive neurons and a better cognitive performance as analyzed with Morris water maze test. These data provide substantial evidence that neuroprotection upon CR seems to be Fgf21-dependent. Further experiments are necessary to evaluate Fgf21 as a therapeutic tool to treat tauopathy for improvement of cognitive performance. FAU - Ruhlmann, Claire AU - Ruhlmann C AD - Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany. FAU - Wolk, Tjark AU - Wolk T AD - Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany. FAU - Blumel, Tobias AU - Blumel T AD - Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany. FAU - Stahn, Laura AU - Stahn L AD - Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany. FAU - Vollmar, Brigitte AU - Vollmar B AD - Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany. FAU - Kuhla, Angela AU - Kuhla A AD - Institute for Experimental Surgery, Rostock University Medical Center, 18057 Rostock, Germany. LA - eng PT - Journal Article PL - United States TA - Aging (Albany NY) JT - Aging JID - 101508617 RN - 0 (Apolipoproteins E) RN - 0 (Receptors, Fibroblast Growth Factor) RN - 0 (fibroblast growth factor-21 receptor, mouse) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) SB - IM MH - AMP-Activated Protein Kinases/*metabolism MH - Aging/*physiology MH - Alzheimer Disease MH - Animals MH - Apolipoproteins E/*deficiency MH - *Caloric Restriction MH - Cognition MH - Disease Models, Animal MH - Female MH - Maze Learning MH - Mice MH - Neurofibrillary Tangles MH - Neuroprotection/genetics/*physiology MH - Receptors, Fibroblast Growth Factor/genetics/*metabolism MH - Signal Transduction MH - TOR Serine-Threonine Kinases/metabolism MH - Up-Regulation PMC - PMC5191869 OTO - NOTNLM OT - Alzheimer s disease OT - Fgf21 OT - Tau-phosphorylation OT - caloric restriction OT - deficiency ApoE- OT - mTOR OT - pAMPK COIS- The other authors declare that they have no conflict of interest. EDAT- 2016/12/03 06:00 MHDA- 2017/11/07 06:00 PMCR- 2016/11/01 CRDT- 2016/12/01 06:00 PHST- 2016/07/01 00:00 [received] PHST- 2016/11/14 00:00 [accepted] PHST- 2016/12/03 06:00 [pubmed] PHST- 2017/11/07 06:00 [medline] PHST- 2016/12/01 06:00 [entrez] PHST- 2016/11/01 00:00 [pmc-release] AID - 101086 [pii] AID - 10.18632/aging.101086 [doi] PST - ppublish SO - Aging (Albany NY). 2016 Nov 29;8(11):2777-2789. doi: 10.18632/aging.101086.